These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 31492)
41. Effect of beta adrenergic blocking drugs on the renin-aldosterone system, sodium excretion, and renal hemodynamics in cirrhosis with ascites. Wilkinson SP; Bernardi M; Smith IK; Jowett TP; Slater JD; Williams R Gastroenterology; 1977 Oct; 73(4 Pt 1):659-63. PubMed ID: 19338 [TBL] [Abstract][Full Text] [Related]
42. [Renin-angiotensin-aldosterone system in the treatment of essential hypertension with a beta-adrenergic blocker: sotalol]. Psadas C; Sánchez G; Zaldívar HM; Rangel J; Cuéllar A; Serrano PA Arch Inst Cardiol Mex; 1977; 47(2):160-70. PubMed ID: 901052 [TBL] [Abstract][Full Text] [Related]
43. [Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients]. Higuma K; Fujishima S; Shionoiri H; Tochikubo O; Uneda S; Fujiki Y; Kaneko Y Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):425-35. PubMed ID: 6381833 [No Abstract] [Full Text] [Related]
44. The pathophysiology of renovascular hypertension. Robertson JI; Morton JJ; Tillman DM; Lever AF J Hypertens Suppl; 1986 Oct; 4(4):S95-103. PubMed ID: 3534187 [TBL] [Abstract][Full Text] [Related]
45. Hormonal profiling in the diagnosis and treatment of essential hypertension. Laragh JH Del Med J; 1974 Mar; 46(3):125-33. PubMed ID: 4361408 [No Abstract] [Full Text] [Related]
46. The renin system and new understanding of the complications of hypertension and their treatment. Laragh JH Arzneimittelforschung; 1993 Feb; 43(2A):247-54. PubMed ID: 8498972 [TBL] [Abstract][Full Text] [Related]
47. Role of the renin-angiotensin-aldosterone system in the regulation of blood pressure. Barger AC Adv Nephrol Necker Hosp; 1980; 9():271-93. PubMed ID: 6250379 [No Abstract] [Full Text] [Related]
49. The role of renin in the control of the circulation and in hypertensive disease. Haber E Ric Clin Lab; 1979; 9(4):389-409. PubMed ID: 397605 [TBL] [Abstract][Full Text] [Related]
52. A beta-blocker-based antihypertensive drug program guided by age and renin. Bühler FR; Lütold BE Aust N Z J Med; 1976 Aug; 6(3 Suppl):29-36. PubMed ID: 14622 [TBL] [Abstract][Full Text] [Related]
53. Abnormal sodium metabolism and plasma renin activity (renal renin secretion) and the vasoconstriction volume hypothesis: implications for pathogenesis and treatment of hypertension and its vascular consequences (heart attack, stroke). Laragh JH; Sealey JE Clin Chem; 1991 Oct; 37(10 Pt 2):1820-7. PubMed ID: 1914196 [TBL] [Abstract][Full Text] [Related]
54. Two forms of vasoconstriction in systemic hypertension. Laragh JH Am J Cardiol; 1987 Oct; 60(12):82G-93G. PubMed ID: 3314453 [TBL] [Abstract][Full Text] [Related]
55. Renin and beta-adenoceptor blockade-the mechanism of the hypotensive effect? Hamer J Br J Clin Pharmacol; 1976 Jun; 3(3):425-7. PubMed ID: 9962 [No Abstract] [Full Text] [Related]
56. The renin system for long-term control over vasoconstriction and sodium-volume homeostasis in the spectrum of hypertension: three new frontiers in research. Laragh JH Clin Exp Hypertens A; 1983; 5(7-8):921-39. PubMed ID: 6357565 [TBL] [Abstract][Full Text] [Related]
57. Is the renin-sodium profile helpful in evaluating hypertension? Gifford RW JAMA; 1980 Jul; 244(1):35-7. PubMed ID: 6991725 [No Abstract] [Full Text] [Related]
58. Reminiscences and reflections. Haas E J Hypertens Suppl; 1986 Oct; 4(4):S21-5. PubMed ID: 3534181 [TBL] [Abstract][Full Text] [Related]